JOSHUA RADECKI: Open Payments
NPI 1215311972 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,598 in 116 payments from 26 companies in 2025. Trend: 2023 $2,530 · 2024 $2,995 · 2025 $2,598
Food & beverage: $2,319Education: $279
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $371 |
| GlaxoSmithKline, LLC. | 17 | $279 |
| PFIZER INC. | 11 | $223 |
| Lilly USA, LLC | 11 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $190 |
| Viatris Specialty LLC | 8 | $179 |
| Novo Nordisk Inc | 9 | $151 |
| AstraZeneca Pharmaceuticals LP | 7 | $144 |
| Dexcom, Inc. | 2 | $141 |
| Exact Sciences Corporation | 5 | $117 |
Products named: General - Brady, TRELEGY ELLIPTA, CAPLYTA, YUPELRI, REXULTI, DEXCOM G7 GSS (161), NURTEC ODT, MOUNJARO.
Industry payments across NY — which companies pay providers there.
